Skip to main content

William Vernier, Kevin Cooksy, Julie Brooks, Brenda Rogers, Kavita Reddy, Jose Ordovas

Premium
Clinical Data has named William Vernier to be VP of operations in the company’s PGxHealth division. Vernier formerly worked at Quest Diagnostics.
 

 
Perlegen announced three new hires last week, naming Kevin Cooksy to be VP of business development, Julie Brooks as general counsel and corporate secretary, and Brenda Rogers to be VP of human resources. Cooksy previously was involved in corporate development at Agilent Technologies; Brooks served in a variety of legal and corporate management positions at healthcare technology companies, including Westmark Intrenational and Access Health; and Rogers was a consultant to biotech companies and was VP of human resources at OneWorld Health.
 

 
CombiMatrix Molecular Diagnostics has hired Kavita Reddy to be its laboratory director. Reddy formerly was senior director of Genzyme Genetics in Manhattan, and an associate director and scientific director of Quest Diagnostics.
 

 
Progenika has appointed Jose Ordovas, director of the Nutrition and Genomics Laboratory at Tufts University, to its scientific advisory board.
 
Ordovas has been a researcher in the Framingham Heart Study for more than 20 years, has published more than 400 articles in peer review journals, serves on the editorial boards of several journals, and holds membership with several American Heart Association and National Institutes of Health committees.

Filed under

The Scan

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.

J&J Vaccine Benefits Outweighs Risk, EMA Says

The European Medicines Agency recommends that a warning about the possibility of blood clots be added to the product information.